临床试验

Bionic Pancreas in CFRD

NCT：NCT06449677 · ACTIVE_NOT_RECRUITING

NCT编号NCT06449677

状态ACTIVE_NOT_RECRUITING

开始日期2024-09-24

完成时间2027-05-31

SponsorJaeb Center for Health Research (OTHER)

First posted2024-06-10

Last updated2026-09-18

简要摘要

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。